Although several cytokines and chemokines have been demonstrated to play pivotal roles in the pathophysiological conditions of atherosclerosis, few findings exist regarding the expression and function of cytokine-modulating molecules such as ephrin-Bs and their cognate receptors, EphBs, in human atherosclerosis. Therefore, in the present study, we screened novel genes modulating atherogenesis by cDNA array and quantitatively determined them by real-time RT (reverse transcription)-PCR in human carotid atherosclerotic plaques. Ephrin-B1 and EphB2, key regulators of embryogenesis, were significantly up-regulated in plaques compared with those in adjacent control tissues [ephrin-B1, 0.638±0.106 compared with 0.831±0.152, or 130% (P<0.05); EphB2, 1.296±0.281 compared with 2.233±0.506, or 172% (P<0.05)]. Immunohistological analysis demonstrated that both ephrin-B1 and EphB2 were expressed in macrophages and T-lymphocytes in plaques as well as in monocytes, T-lymphocytes and arterial endothelial cells isolated from healthy adults. Interestingly, the extracellular domains of ephrin-B1 and EphB2, the expression of which were both enhanced in stimulated THP-1 cells, significantly inhibited spontaneous (22.5 and 27.6% respectively; P<0.01) and MCP-1 (monocyte chemoattractant protein-1)-dependent (29.7 and 22.6% respectively; P<0.01) migration of monocytes. In conclusion, these results demonstrate that ephrin-B1 and EphB2 are overexpressed in atherosclerotic tissue and might locally regulate cell migration, possibly through modulating cytokine-related chemotaxic activity; however, the functional role of these molecules in atherogenesis should be investigated further.
Skip Nav Destination
Article navigation
May 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
April 14 2008
Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis
Aiji Sakamoto;
Aiji Sakamoto
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Hatsue Ishibashi-Ueda;
Hatsue Ishibashi-Ueda
†Division of Pathology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Yuka Sugamoto;
Yuka Sugamoto
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Takeo Higashikata;
Takeo Higashikata
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Susumu Miyamoto;
Susumu Miyamoto
‡Division of Neurosurgery, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Masa-aki Kawashiri;
Masa-aki Kawashiri
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Kunimasa Yagi;
Kunimasa Yagi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Tetsuo Konno;
Tetsuo Konno
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Kenshi Hayashi;
Kenshi Hayashi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Noboru Fujino;
Noboru Fujino
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Hidekazu Ino;
Hidekazu Ino
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Yoshiyu Takeda;
Yoshiyu Takeda
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Masakazu Yamagishi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Correspondence: Dr Masakazu Yamagishi (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
September 25 2007
Revision Received:
November 15 2007
Accepted:
December 19 2007
Accepted Manuscript online:
December 19 2007
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2008 Biochemical Society
2008
Clin Sci (Lond) (2008) 114 (10): 643–650.
Article history
Received:
September 25 2007
Revision Received:
November 15 2007
Accepted:
December 19 2007
Accepted Manuscript online:
December 19 2007
Citation
Aiji Sakamoto, Hatsue Ishibashi-Ueda, Yuka Sugamoto, Takeo Higashikata, Susumu Miyamoto, Masa-aki Kawashiri, Kunimasa Yagi, Tetsuo Konno, Kenshi Hayashi, Noboru Fujino, Hidekazu Ino, Yoshiyu Takeda, Masakazu Yamagishi; Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. Clin Sci (Lond) 1 May 2008; 114 (10): 643–650. doi: https://doi.org/10.1042/CS20070339
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |